Related Experiment Video
Updated: Jun 24, 2025

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
The Impact of Juvenile Microglia Transcriptomics on the Adult Brain Regeneration after Cerebral Ischemia
Flavia Semida Ghinea1, Marius Viorel Ionică1, Ilona Mihaela Liliac2
1Experimental Research Center for Normal and Pathological Aging, University of Medicine and Medicine Craiova, Romania.
Abstract:
Microglial cells play a pivotal role in the brain's health and operation through all stages of life and in the face of illness. The contributions of microglia during the developmental phase of the brain markedly contrast with their contributions in the brain of adults after injury. Enhancing our understanding of the pathological mechanisms that involve microglial activity in brains as they age and in cerebrovascular conditions is crucial for informing the creation of novel therapeutic approaches. In this work we provide results on microglia transcriptomics in the juvenile vs injured adult brain and its impact on adult brain regeneration after cerebral ischemia. During fetal brain development, microglia cells are involved in gliogenesis, angiogenesis, axonal outgrowth, synaptogenesis, neurogenesis and synaptic reorganization by engulfing neuronal extensions. Within the mature, intact brain, microglial cells exhibit reduced movement of their processes in response to minimal neuronal activity, while they continuously monitor their surroundings and clear away cellular debris. Following a stroke in the adult brain, inflammation, neurodegeneration, or disruptions in neural equilibrium trigger alterations in both the genetic blueprint and the structure and roles of microglia, a state often described as "activated" microglia. Such genetic shifts include a notable increase in the pathways related to phagosomes, lysosomes, and the presentation of antigens, coupled with a rise in the expression of genes linked to cell surface receptors. We conclude that a comparison of microglia transcriptomic activity during brain development and post-stroke adult brain might provide us with new clues about how neurodegeneration occurs in the adult brain. This information could very useful to develop drugs to slow down or limit the post-stroke pathology and improve clinical outcome.
Insights
Comparing microglia transcriptomics in juvenile and injured adult brains reveals key differences. This comparison offers insights into adult brain regeneration and potential therapeutic targets for stroke recovery.
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Microglial cells are crucial for brain health throughout life, with distinct roles in development versus adulthood.
- Understanding microglial responses to aging and cerebrovascular conditions is vital for developing new therapies.
- Microglial functions shift significantly from development to adulthood, especially after injury like stroke.
Purpose of the Study:
- To compare microglia transcriptomics between juvenile and injured adult brains.
- To investigate the impact of these transcriptomic differences on adult brain regeneration after cerebral ischemia.
- To identify potential therapeutic targets for post-stroke pathology.
Main Methods:
- Transcriptomic analysis of microglial cells.
- Comparison of gene expression profiles in juvenile versus post-stroke adult brains.
- Analysis of pathways related to phagosomes, lysosomes, and antigen presentation.
Main Results:
- Microglia exhibit distinct transcriptomic profiles during brain development compared to injured adult states.
- Post-stroke microglia show increased expression of genes involved in phagosomes, lysosomes, and antigen presentation.
- These changes suggest altered roles in immune response and debris clearance in adult brains after injury.
Conclusions:
- Comparing developmental and post-stroke microglial transcriptomes provides insights into adult neurodegeneration mechanisms.
- Identifying these differences can guide the development of drugs to mitigate post-stroke pathology.
- This research may lead to improved clinical outcomes for stroke patients.

